Trials / Completed
CompletedNCT03510533
Validation of the Concept of the Autoantibodies Directed Against the Neuropeptides Involved in Food Intake Regulation on the Incidental Cases of Eating Disorders
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 211 (actual)
- Sponsor
- University Hospital, Rouen · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
This study should lead to the validation of the concept of the autoAc directed against the neuropeptides involved in food intake regulation.
Detailed description
Eating disorders are a public health issue. It has been recently reported the importance of immune system modifications in eating disorders physiopathology, involving autoantibodies directed against neuropeptides regulating food intake. A recent study of laboratory INSERM 1073 showed the existence of an intestinal bacterial protein exhibiting structural similarities with α-MSH: ClpB. The autoAc directed against the latter also react with α-MSH because of these similarity of structures, thus leading to a potential digestive origin of these autoAc. To consolidate this new etiopathogenic assumption, a large clinical study is necessary with analysis of patients autoAc profiles. a monocentric study with inclusion of 240 patients over 2 years and 80 healthy volunteers is proposed. This study should lead to the validation of the concept of the autoAc directed against the neuropeptides involved in food intake regulation. Nutritional modulations (probiotic, amino-acid…) could constitute an interesting therapeutic perspective in the future.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Evaluation of the rates of the autoantibodies directed against the neuropeptides (ghrelin and alpha-MSH) controlling involved in food intake regulation | blood samples (12ml) and stool samples (30g) collections |
Timeline
- Start date
- 2018-05-24
- Primary completion
- 2025-08-13
- Completion
- 2025-08-13
- First posted
- 2018-04-27
- Last updated
- 2026-02-06
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03510533. Inclusion in this directory is not an endorsement.